Liver Disease and Treatment Needs of Asymptomatic Persons Living With Hepatitis B in Senegal

Adrià Ramírez Mena, Mame Aissé Thioubou, Kalilou Diallo, Judicaël Tine, Ndeye Fatou Ngom, Louise Fortes, Kiné Ndiaye, Jean Claude Karasi, Carole Seguin-Devaux, Henri Goedertz, Daouda Diouf, Moussa Seydi, Benjamin Amaye Sambou, Vic Arendt, Gilles Wandeler*, Noël Magloire Manga, for SEN-B and CARES

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The prevalence of active hepatitis B among asymptomatic persons remains unclear in Africa. Of 1206 newly diagnosed persons in Senegal, 12.3% had significant fibrosis and 31.3% had hepatitis B virus (HBV) DNA levels >2000 IU/mL. Overall, 128 (12.9%) were eligible for antiviral therapy. Generalized HBV screening allowed the identification of a large population requiring HBV care.

Original languageEnglish
Article numberofac558
JournalOpen Forum Infectious Diseases
Volume9
Issue number11
DOIs
Publication statusPublished - 1 Nov 2022

Keywords

  • hepatitis B
  • liver fibrosis
  • Senegal

Fingerprint

Dive into the research topics of 'Liver Disease and Treatment Needs of Asymptomatic Persons Living With Hepatitis B in Senegal'. Together they form a unique fingerprint.

Cite this